NFE2L2 and pancreatic intraductal papillary-mucinous neoplasm: In Experiment 2, 36 PDAC, 10 IPMN, and 5 control subjects were subjected to blood serum analyses for the evaluation of the PRX3 protein via ELISA, and PRX3, Nrf2, CD44v9, FOXO3a, and p62 mRNA from EVs were evaluated using RT-PCR.